Showing results (1201-1210 of 1,436) with videos related to

Sort By:
Pageof 144
Annals of Surgical Oncology|January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
Cancer|December 20, 2011
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiationJiansheng Wang, Jeannelyn S Estrella, Lan Peng, et al.
BJC Reports|November 8, 2024
New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasisIsha Khanduri, Harufumi Maki, Anuj Verma, et al.
Neurourology and Urodynamics|January 19, 2023
Sleep Disorders, Comorbidities, Actions, Lower Urinary Tract Dysfunction, and Medications ("Sleep C.A.L.M.") in the evaluation and management of nocturia: A simple approach to a complex diagnosisThomas F Monaghan, Jeffrey P Weiss, Alan J Wein, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 13, 2019
Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastasesDavid B Nelson, Nabihah Tayob, Kyle G Mitchell, et al.
Cell Cycle (Georgetown, Tex.)|June 14, 2013
Predicting therapy response in live tumor cells isolated with the flexible micro spring array deviceJean-Nicolas Gallant, Elizabeth M Matthew, Hairong Cheng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Clinical Imaging|February 6, 2026
Two-dimensional venogram following portal venous embolization as a predictor for future liver remnant hypertrophyAaron T Luong, Dominic Bolinas, Allan John R Barcena, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
Oncoimmunology|February 16, 2017
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancerLaurence Buisseret, Soizic Garaud, Alexandre de Wind, et al.
Pageof 144